Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Karol Gema Hernandez, M.D. [2]
Definition
This section provides a short and straight to the point definition of the disease or symptom in one sentence.
Causes
Life Threatening Causes
Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated.
Common Causes
Clinical Clues to the Diagnosis of RAS
| | | | | ❑ Determine if one or more of the above is present | | |
| | | | | | | | | | | | | | | |
| | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | ❑If one or more of the above are present, proceed to further diagnostic testing | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | |
| | Noninvasive Imaging
| | | | Invasive Imaging
|
| | | | | | | | | | | | | |
| | ❑ Duplex ultrasound
❑ Gadolinium enhanced MRA
❑ CT angiography | | | | ❑ Abdominal aortography to assess the renal arteries during coronary and peripheral angiography |
| | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
Negative noninvasive test but with high clinical suspicion | | Evidence of RAS | | Evidence of RAS |
| | | | | | | | | | | | | | | | | |
Renal angiography | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
Evidence of RAS | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
Confirmed RAS, proceed to treatment | | | | | | | | | | | | | | | | |
Algorithm based on the 2013 AHA Guidelines Recommendations for Management of Patients with PAD.[1]
Indications for Renal Revascularization
Indication | Level of evidence |
1.Hemodynamically significant RAS with recurrent, unexplained CHF or sudden, unexplained pulmonary edema | Class I; LOE B |
2. RAS with:
- Accelerated, resistant, or malignant hyper tension
- Hypertension with unilateral small kidney
- Hypertension with medication intolerance
| Class IIa; LOE B |
3.RAS and CRI with bilateral RAS or RAS to solitary functioning kidney | Class IIa; LOE B |
4. RAS and unstable angina | Class IIa; LOE B |
5. Asymptomatic bilateral or solitary viableʰ kidney with a hemodynamically significant RAS | Class IIb; LOE C |
6. Asymptomatic unilateral hemodynamically significant RAS in a viable* kidney | Class IIb; LOE C |
7. RAS and CRI with unilateral RAS (2 kidneys present) | Class IIb; LOE C |
ʰViable means kidney linear length greater than 7 cm
| | | | | | | | ❑ When any of the indications are met: | | |
| | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | ❑Renal Angioplasty/Stent | | | | ❑ Renal artery surgery | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | |
| | Atherosclerotic RAS
| | | | Fibromuscular dysplasia RAS
|
| | | | | | | | | | | | | |
| | Renal stent placement is indicated for ostial atherosclerotic RAS lesions that meet the clinical criteria for intervention | | | | Balloon angioplasty with bailout stent placement if necessary is recommended for fibromuscular dysplasia lesions | |
References
Template:WikiDoc Sources
|